Brand family
Shingrix
Zoster vaccine recombinant, adjuvanted and Herpes zoster vaccine (recombinant, adjuvanted) · GlaxoSmithKline Biologicals
European UnionUnited States
- Presentations
- 2
- Markets
- 2
Shingrix is a brand of Zoster vaccine recombinant, adjuvanted and Herpes zoster vaccine (recombinant, adjuvanted) marketed by GlaxoSmithKline Biologicals, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Zoster vaccine recombinant, adjuvanted, Herpes zoster vaccine (recombinant, adjuvanted)
- Brand owner
- GlaxoSmithKline Biologicals
- Registered in
- European Union, United States
- Strengths and forms
- injection, kit
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Shingrix injectionIntramuscular | GlaxoSmithKline Biologicals | US FDA | Available on request |
| Shingrix kit | GlaxoSmithKline Biologicals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Shingrix
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.